Renchi Yang

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 17

Top Topics

Replacement Therapy

Recombinant Human

Acute Lymphoblastic Leukemia

Peritoneal Dialysis

Top Venues

Haemophilia : the official journal of the World Federation of Hemophilia

Research and practice in thrombosis and haemostasis

Journal of thrombosis and thrombolysis

Annals of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Yunfei Chen, Yanmei Xu, Yueting Huang, Ting Sun, Yuefen Hu, Feng Xue, Xuanwei Peng, Yinghui Lai, Zeping Zhou, Hu Zhou, Rongfu Zhou, Wei Liu, Xiaofan Liu, Huan Dong, Rongfeng Fu, Mankai Ju, Xinyue Dai, Huiyuan Li, Xiaonan Liu, Yueshen Ma, Zhen Song, Jun Peng, Renchi Yang, Lei Zhang
Efficacy and safety of eltrombopag in the treatment of immune thrombocytopenia patients with hepatitis B virus infection: A prospective, multicenter, single arm, phase II trial. American journal of hematology (2023)
Wenhui Zhang, Shitong Xie, Rongfeng Fu, Yunfei Chen, Wei Liu, Ting Sun, Mankai Ju, Huiyuan Li, Feng Xue, Lei Zhang, Xiaofan Liu, Renchi Yang
Fatigue and health-related quality of life in patients with immune thrombocytopenia: a longitudinal assessment in China. Expert review of hematology (2023)
Xiaofan Liu, Yusheng Bai, Tao Wang, Yanping Song, Feng Sun, Ruixiang Xia, Feiyue Zhu, Jun Ma, Quanyi Lu, Xu Ye, Xinrong Zhan, Linjie Li, Xinhong Guo, Shuqin Cheng, Yan Li, Zhiqiang Guo, Youhua Chen, Shenxian Qian, Ling Qin, Qing Zhang, Sunqiong Cao, Renchi Yang
Recombinant human thrombopoietin (rhTPO) of different dosing regimens for refractory/relapsed primary immune thrombocytopenia: a multicenter, randomized controlled trial and pharmacokinetics study. Platelets 34 (1) (2023)
Rongfeng Fu, Huan Dong, Donglei Zhang, Hu Zhou, Xian Zhang, Yueting Huang, Xiaofan Liu, Feng Xue, Wei Liu, Yunfei Chen, Ting Sun, Mankai Ju, Xinyue Dai, Renchi Yang, Lei Zhang
Clinical features and current treatment status of essential thrombocythemia in older adults: a multicenter real-world study in China. Annals of hematology (2023)
Jia Chen, Huan Dong, Rongfeng Fu, Xiaofan Liu, Feng Xue, Wei Liu, Yunfei Chen, Ting Sun, Mankai Ju, Xinyue Dai, Huiyuan Li, Wentian Wang, Ying Chi, Renchi Yang, Lei Zhang
Machine learning analyses constructed a novel model to predict recurrent thrombosis in adults with essential thrombocythemia. Journal of thrombosis and thrombolysis (2023)
Xiaohong Sun, Wei Liu, Binyu Luo, Dongwei Ma, Hindu Kalluru, Yangmei Zhou, Jin Li, Ao Peng, Yuwang Liu, Xin Tong, Lei Sun, John Teeter, Sangeeta Raje, Renchi Yang
Safety, tolerability, pharmacokinetics and pharmacodynamics of a single dose of marstacimab in Chinese participants with severe haemophilia. Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Cuiyun Qu, Wei Liu, Lingling Chen, Lei Zhang, Feng Xue, Renchi Yang
Analysis of hospitalization of people with hemophilia-12 years of experience in a single center. Research and practice in thrombosis and haemostasis 6 (5) (2022)
Xinsheng Zhang, Xuewen Song, Xueqing Dou, Man-Chiu Poon, Xiaohong Sun, Lingling Chen, Lei Zhang, Feng Xue, Renchi Yang
Demographics, clinical profile and treatment landscape of patients with haemophilia B in China. Haemophilia : the official journal of the World Federation of Hemophilia 28 (2) (2022)
Wei Liu, Cuicui Lyu, Wentian Wang, Feng Xue, Lingling Chen, Huiyuan Li, Ying Chi, Yueshen Ma, Runhui Wu, Yunhai Fang, Lei Zhang, Renchi Yang
Risk factors for inhibitors in hemophilia A based on RNA-seq and DNA methylation. Research and practice in thrombosis and haemostasis 6 (6) (2022)
Cuiyun Qu, Wei Liu, Lingling Chen, Lei Zhang, Feng Xue, Renchi Yang
Factor VII deficiency in China: Phenotype, genotype and current status of management. British journal of haematology (2022)
Renchi Yang, Shujie Wang, Xuefeng Wang, Jing Sun, Ampaiwan Chuansumrit, Jianfeng Zhou, Christophe Schmitt, Wanling Hsu, Jeffrey Xu, Lindong Li, Tiffany Chang, Xielan Zhao
Prophylactic emicizumab for hemophilia A in the Asia-Pacific region: A randomized study (HAVEN 5). Research and practice in thrombosis and haemostasis 6 (2) (2022)
Xuewen Song, Wei Liu, Feng Xue, Jia Zhong, Yifan Yang, Yi Liu, Jipan Xie, Eric Wu, Lei Zhang, Jun Shi, Renchi Yang
Real-world analysis of haemophilia patients in China: A single centre's experience. Haemophilia : the official journal of the World Federation of Hemophilia 26 (4) (2020)
Xueqing Dou, Man-Chiu Poon, Renchi Yang
Haemophilia care in China: Achievements in the past decade. Haemophilia : the official journal of the World Federation of Hemophilia 26 (5) (2020)
Ai Zhang, Xiaohong Sun, Man-Chiu Poon, Aiguo Liu, Xiaoping Luo, Lingling Chen, Qun Hu, Renchi Yang
Management of haemophilia patients in the COVID-19 pandemic: Experience in Wuhan and Tianjin, two differently affected cities in China. Haemophilia : the official journal of the World Federation of Hemophilia 26 (6) (2020)
Xuewen Song, Jia Zhong, Feng Xue, Lingling Chen, Huiyuan Li, Donghui Yuan, Jipan Xie, Jun Shi, Lei Zhang, Eric Q Wu, Renchi Yang
An overview of patients with haemophilia A in China: Epidemiology, disease severity and treatment strategies. Haemophilia : the official journal of the World Federation of Hemophilia 27 (1) (2020)
Johnny N Mahlangu, Johannes Oldenburg, Michael U Callaghan, Midori Shima, Maria Elisa Mancuso, Peter Trask, Michael Recht, Claudia Garcia, Renchi Yang, Michaela Lehle, Harrison Macharia, Elina Asikanius, Gallia G Levy, Rebecca Kruse-Jarres, Sylvia von Mackensen
Health-related quality of life and health status in persons with haemophilia A with inhibitors: A prospective, multicentre, non-interventional study (NIS). Haemophilia : the official journal of the World Federation of Hemophilia 25 (3) (2019)
Renchi Yang, Jing Sun, Yongqiang Zhao, Xuefeng Wang, Depei Wu, Despina Tseneklidou-Stoeter, Junde Wu, Nikki Church
Efficacy and safety of prophylaxis with BAY 81-8973 in Chinese patients with severe haemophilia A enrolled in the LEOPOLD II trial. Haemophilia : the official journal of the World Federation of Hemophilia 25 (3) (2019)